ID   KIF1B_HUMAN             Reviewed;        1816 AA.
AC   O60333; A6NFS8; A6NKQ4; Q4VXC3; Q4VXC4; Q4VXC5; Q4VXC6; Q96Q94; Q9BV80;
AC   Q9P280;
DT   11-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 5.
DT   07-APR-2021, entry version 217.
DE   RecName: Full=Kinesin-like protein KIF1B;
DE            Short=Klp;
GN   Name=KIF1B; Synonyms=KIAA0591, KIAA1448;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RA   Bougueleret L., Dufaure-Gare I., Grel P.;
RT   "DNA encoding a kinesin-like protein (hklp) comprising biallelic markers.";
RL   Patent number WO0063375, 26-OCT-2000.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4), AND TISSUE SPECIFICITY.
RC   TISSUE=Substantia nigra;
RX   PubMed=10762626; DOI=10.3892/ijo.16.5.907;
RA   Nagai M., Ichimiya S., Ozaki T., Seki N., Mihara M., Furuta S., Ohira M.,
RA   Tomioka N., Nomura N., Sakiyama S., Kubo O., Takakura K., Hori T.,
RA   Nakagawara A.;
RT   "Identification of the full-length KIAA0591 gene encoding a novel kinesin-
RT   related protein which is mapped to the neuroblastoma suppressor gene locus
RT   at 1p36.2.";
RL   Int. J. Oncol. 16:907-916(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 2), AND TISSUE SPECIFICITY.
RX   PubMed=11526494; DOI=10.1038/sj.onc.1204456;
RA   Yang H.W., Chen Y.Z., Takita J., Soeda E., Piao H.Y., Hayashi Y.;
RT   "Genomic structure and mutational analysis of the human KIF1B gene which is
RT   homozygously deleted in neuroblastoma at chromosome 1p36.2.";
RL   Oncogene 20:5075-5083(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RA   Park M., Shin H., Lee Y.M., Moon E., Choi W., Kim W.;
RT   "Identification of the human ortholog of mouse Kif1B, a kinesin superfamily
RT   motor protein.";
RL   Submitted (JUL-2001) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4).
RA   Munirajan A.K., Ohira M., Nakagawara A.;
RT   "Identification of splicing variants of KIF1Bbeta.";
RL   Submitted (JUL-2002) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), AND TISSUE SPECIFICITY.
RC   TISSUE=Neuroblastoma;
RX   PubMed=12888911;
RA   Chen Y.Y., Takita J., Chen Y.Z., Yang H.W., Hanada R., Yamamoto K.,
RA   Hayashi Y.;
RT   "Genomic structure and mutational analysis of the human KIF1Balpha gene
RT   located at 1p36.2 in neuroblastoma.";
RL   Int. J. Oncol. 23:737-744(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9628581; DOI=10.1093/dnares/5.1.31;
RA   Nagase T., Ishikawa K., Miyajima N., Tanaka A., Kotani H., Nomura N.,
RA   Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. IX. The
RT   complete sequences of 100 new cDNA clones from brain which can code for
RT   large proteins in vitro.";
RL   DNA Res. 5:31-39(1998).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Brain;
RX   PubMed=10819331; DOI=10.1093/dnares/7.2.143;
RA   Nagase T., Kikuno R., Ishikawa K., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XVII. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 7:143-150(2000).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 1238-1816 (ISOFORMS 1/2).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1238-1816 (ISOFORMS 1/2).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1449-1816 (ISOFORMS 1/2).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [13]
RP   INTERACTION WITH KIFBP, AND SUBCELLULAR LOCATION.
RX   PubMed=16225668; DOI=10.1186/1471-2121-6-35;
RA   Wozniak M.J., Melzer M., Dorner C., Haring H.U., Lammers R.;
RT   "The novel protein KBP regulates mitochondria localization by interaction
RT   with a kinesin-like protein.";
RL   BMC Cell Biol. 6:35-35(2005).
RN   [14]
RP   FUNCTION, INVOLVEMENT IN NEUROBLASTOMA AND PHEOCHROMOCYTOMA, AND VARIANTS
RP   LEU-34; VAL-692; ILE-873; CYS-1133; SER-1263; ASN-1527; MET-1600 AND
RP   LYS-1674.
RX   PubMed=18334619; DOI=10.1101/gad.1648608;
RA   Schlisio S., Kenchappa R.S., Vredeveld L.C., George R.E., Stewart R.,
RA   Greulich H., Shahriari K., Nguyen N.V., Pigny P., Dahia P.L., Pomeroy S.L.,
RA   Maris J.M., Look A.T., Meyerson M., Peeper D.S., Carter B.D.,
RA   Kaelin W.G. Jr.;
RT   "The kinesin KIF1Bbeta acts downstream from EglN3 to induce apoptosis and
RT   is a potential 1p36 tumor suppressor.";
RL   Genes Dev. 22:884-893(2008).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1057, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1075 AND SER-1487, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1057; SER-1454; SER-1487;
RP   SER-1610 AND SER-1613, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1141
RP   (ISOFORM 3), AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-663 AND SER-665 (ISOFORM 3),
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [21]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1054; SER-1057; SER-1416;
RP   SER-1454 AND SER-1487, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1454; SER-1573; SER-1603 AND
RP   SER-1613, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-665 (ISOFORM 3),
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [24]
RP   VARIANT CMT2A1 LEU-98.
RX   PubMed=11389829; DOI=10.1016/s0092-8674(01)00363-4;
RA   Zhao C., Takita J., Tanaka Y., Setou M., Nakagawa T., Takeda S., Yang H.W.,
RA   Terada S., Nakata T., Takei Y., Saito M., Tsuji S., Hayashi Y.,
RA   Hirokawa N.;
RT   "Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule
RT   motor KIF1B-beta.";
RL   Cell 105:587-597(2001).
CC   -!- FUNCTION: Motor for anterograde transport of mitochondria. Has a
CC       microtubule plus end-directed motility. Isoform 2 is required for
CC       induction of neuronal apoptosis. {ECO:0000269|PubMed:18334619}.
CC   -!- FUNCTION: Isoform 1 mediates the transport of synaptic vesicles in
CC       neuronal cells. {ECO:0000250|UniProtKB:O88658}.
CC   -!- SUBUNIT: Monomer (By similarity). Interacts (via C-terminus end of the
CC       kinesin-motor domain) with CHP1; the interaction occurs in a calcium-
CC       dependent manner (By similarity). Interacts with KIFBP
CC       (PubMed:16225668). {ECO:0000250|UniProtKB:O88658,
CC       ECO:0000250|UniProtKB:Q60575, ECO:0000269|PubMed:16225668}.
CC   -!- INTERACTION:
CC       O60333; Q7Z460: CLASP1; NbExp=3; IntAct=EBI-465633, EBI-913476;
CC       O60333; Q8IUQ4: SIAH1; NbExp=3; IntAct=EBI-465633, EBI-747107;
CC       O60333-2; Q6UY14-3: ADAMTSL4; NbExp=3; IntAct=EBI-10975473, EBI-10173507;
CC       O60333-2; P20933: AGA; NbExp=3; IntAct=EBI-10975473, EBI-1223922;
CC       O60333-2; Q6ZTN6-2: ANKRD13D; NbExp=3; IntAct=EBI-10975473, EBI-25840993;
CC       O60333-2; Q92688: ANP32B; NbExp=3; IntAct=EBI-10975473, EBI-762428;
CC       O60333-2; P13928: ANXA8; NbExp=3; IntAct=EBI-10975473, EBI-2556915;
CC       O60333-2; D3DTF8: APLN; NbExp=3; IntAct=EBI-10975473, EBI-22002556;
CC       O60333-2; P05067: APP; NbExp=3; IntAct=EBI-10975473, EBI-77613;
CC       O60333-2; O94778: AQP8; NbExp=3; IntAct=EBI-10975473, EBI-19124986;
CC       O60333-2; Q86TN1: ARNT2; NbExp=3; IntAct=EBI-10975473, EBI-25844820;
CC       O60333-2; Q9Y575-3: ASB3; NbExp=3; IntAct=EBI-10975473, EBI-14199987;
CC       O60333-2; Q96DX5: ASB9; NbExp=3; IntAct=EBI-10975473, EBI-745641;
CC       O60333-2; Q96DX5-3: ASB9; NbExp=3; IntAct=EBI-10975473, EBI-25843552;
CC       O60333-2; Q6XD76: ASCL4; NbExp=3; IntAct=EBI-10975473, EBI-10254793;
CC       O60333-2; Q96FT7-4: ASIC4; NbExp=3; IntAct=EBI-10975473, EBI-9089489;
CC       O60333-2; Q9H0Y0: ATG10; NbExp=3; IntAct=EBI-10975473, EBI-1048913;
CC       O60333-2; P15313: ATP6V1B1; NbExp=3; IntAct=EBI-10975473, EBI-2891281;
CC       O60333-2; P46379-2: BAG6; NbExp=3; IntAct=EBI-10975473, EBI-10988864;
CC       O60333-2; Q9UQB8-6: BAIAP2; NbExp=3; IntAct=EBI-10975473, EBI-9092016;
CC       O60333-2; Q16611: BAK1; NbExp=3; IntAct=EBI-10975473, EBI-519866;
CC       O60333-2; Q8IXM2: BAP18; NbExp=3; IntAct=EBI-10975473, EBI-4280811;
CC       O60333-2; Q16520: BATF; NbExp=3; IntAct=EBI-10975473, EBI-749503;
CC       O60333-2; Q9BXK5: BCL2L13; NbExp=3; IntAct=EBI-10975473, EBI-747430;
CC       O60333-2; Q14457: BECN1; NbExp=3; IntAct=EBI-10975473, EBI-949378;
CC       O60333-2; Q96LC9: BMF; NbExp=3; IntAct=EBI-10975473, EBI-3919268;
CC       O60333-2; Q8WUW1: BRK1; NbExp=3; IntAct=EBI-10975473, EBI-2837444;
CC       O60333-2; Q0VDD7: BRME1; NbExp=3; IntAct=EBI-10975473, EBI-741210;
CC       O60333-2; Q9NSI6-4: BRWD1; NbExp=3; IntAct=EBI-10975473, EBI-10693038;
CC       O60333-2; Q9H0W9-4: C11orf54; NbExp=3; IntAct=EBI-10975473, EBI-25849710;
CC       O60333-2; Q32Q52: C12orf74; NbExp=3; IntAct=EBI-10975473, EBI-12891828;
CC       O60333-2; Q8TAB5: C1orf216; NbExp=3; IntAct=EBI-10975473, EBI-747505;
CC       O60333-2; Q8N865: C7orf31; NbExp=3; IntAct=EBI-10975473, EBI-10174456;
CC       O60333-2; Q96LL4: C8orf48; NbExp=3; IntAct=EBI-10975473, EBI-751596;
CC       O60333-2; Q96NX5: CAMK1G; NbExp=3; IntAct=EBI-10975473, EBI-3920838;
CC       O60333-2; Q8N5S9-2: CAMKK1; NbExp=3; IntAct=EBI-10975473, EBI-25850646;
CC       O60333-2; Q6ZP82: CCDC141; NbExp=3; IntAct=EBI-10975473, EBI-928795;
CC       O60333-2; Q96LX7-5: CCDC17; NbExp=3; IntAct=EBI-10975473, EBI-12165781;
CC       O60333-2; A0A1B0GWI1: CCDC196; NbExp=3; IntAct=EBI-10975473, EBI-10181422;
CC       O60333-2; Q9Y3X0: CCDC9; NbExp=3; IntAct=EBI-10975473, EBI-2557532;
CC       O60333-2; Q9UJX2: CDC23; NbExp=3; IntAct=EBI-10975473, EBI-396137;
CC       O60333-2; Q494V2-2: CFAP100; NbExp=3; IntAct=EBI-10975473, EBI-11953200;
CC       O60333-2; Q9Y3D0: CIAO2B; NbExp=3; IntAct=EBI-10975473, EBI-744045;
CC       O60333-2; Q14677: CLINT1; NbExp=3; IntAct=EBI-10975473, EBI-1171113;
CC       O60333-2; Q96DZ5: CLIP3; NbExp=3; IntAct=EBI-10975473, EBI-12823145;
CC       O60333-2; Q6PJW8-3: CNST; NbExp=3; IntAct=EBI-10975473, EBI-25836090;
CC       O60333-2; Q96MW5: COG8; NbExp=3; IntAct=EBI-10975473, EBI-720875;
CC       O60333-2; Q8IUI8: CRLF3; NbExp=3; IntAct=EBI-10975473, EBI-2872414;
CC       O60333-2; A0A140G945: CRYAA2; NbExp=3; IntAct=EBI-10975473, EBI-25838900;
CC       O60333-2; Q8TB03: CXorf38; NbExp=3; IntAct=EBI-10975473, EBI-12024320;
CC       O60333-2; P00167: CYB5A; NbExp=3; IntAct=EBI-10975473, EBI-1047284;
CC       O60333-2; Q7L576: CYFIP1; NbExp=3; IntAct=EBI-10975473, EBI-1048143;
CC       O60333-2; Q5TAQ9-2: DCAF8; NbExp=3; IntAct=EBI-10975473, EBI-25842815;
CC       O60333-2; Q8NDP9: DKFZp547K2416; NbExp=3; IntAct=EBI-10975473, EBI-25842538;
CC       O60333-2; Q9P1A6-3: DLGAP2; NbExp=3; IntAct=EBI-10975473, EBI-12019838;
CC       O60333-2; Q5VZB9: DMRTA1; NbExp=3; IntAct=EBI-10975473, EBI-3939812;
CC       O60333-2; Q7L591-3: DOK3; NbExp=3; IntAct=EBI-10975473, EBI-10694655;
CC       O60333-2; A0A024RCP2: DOM3Z; NbExp=3; IntAct=EBI-10975473, EBI-25847826;
CC       O60333-2; O14531: DPYSL4; NbExp=3; IntAct=EBI-10975473, EBI-719542;
CC       O60333-2; Q9BPU6: DPYSL5; NbExp=3; IntAct=EBI-10975473, EBI-724653;
CC       O60333-2; Q92997: DVL3; NbExp=3; IntAct=EBI-10975473, EBI-739789;
CC       O60333-2; O75530-2: EED; NbExp=3; IntAct=EBI-10975473, EBI-11132357;
CC       O60333-2; O00303: EIF3F; NbExp=3; IntAct=EBI-10975473, EBI-711990;
CC       O60333-2; Q9H6S3: EPS8L2; NbExp=3; IntAct=EBI-10975473, EBI-3940939;
CC       O60333-2; Q13216-2: ERCC8; NbExp=3; IntAct=EBI-10975473, EBI-16466949;
CC       O60333-2; Q9NQ30: ESM1; NbExp=3; IntAct=EBI-10975473, EBI-12260294;
CC       O60333-2; Q6NXG1: ESRP1; NbExp=3; IntAct=EBI-10975473, EBI-10213520;
CC       O60333-2; Q99504: EYA3; NbExp=3; IntAct=EBI-10975473, EBI-9089567;
CC       O60333-2; O15540: FABP7; NbExp=3; IntAct=EBI-10975473, EBI-10697159;
CC       O60333-2; Q6P1L5: FAM117B; NbExp=3; IntAct=EBI-10975473, EBI-3893327;
CC       O60333-2; Q49AJ0-4: FAM135B; NbExp=3; IntAct=EBI-10975473, EBI-25835236;
CC       O60333-2; Q96GL9: FAM163A; NbExp=3; IntAct=EBI-10975473, EBI-11793142;
CC       O60333-2; Q17RN3: FAM98C; NbExp=3; IntAct=EBI-10975473, EBI-5461838;
CC       O60333-2; Q8IZU1: FAM9A; NbExp=3; IntAct=EBI-10975473, EBI-8468186;
CC       O60333-2; O15287: FANCG; NbExp=3; IntAct=EBI-10975473, EBI-81610;
CC       O60333-2; Q8TC84: FANK1; NbExp=3; IntAct=EBI-10975473, EBI-21975404;
CC       O60333-2; Q53R41: FASTKD1; NbExp=3; IntAct=EBI-10975473, EBI-3957005;
CC       O60333-2; O00757: FBP2; NbExp=3; IntAct=EBI-10975473, EBI-719781;
CC       O60333-2; Q9UHY8: FEZ2; NbExp=3; IntAct=EBI-10975473, EBI-396453;
CC       O60333-2; P15407: FOSL1; NbExp=3; IntAct=EBI-10975473, EBI-744510;
CC       O60333-2; Q8NCL4: GALNT6; NbExp=3; IntAct=EBI-10975473, EBI-3907241;
CC       O60333-2; P15976-2: GATA1; NbExp=3; IntAct=EBI-10975473, EBI-9090198;
CC       O60333-2; Q9NXC2: GFOD1; NbExp=3; IntAct=EBI-10975473, EBI-8799578;
CC       O60333-2; P10075: GLI4; NbExp=3; IntAct=EBI-10975473, EBI-14061927;
CC       O60333-2; Q9HBQ8: GOLGA2P5; NbExp=3; IntAct=EBI-10975473, EBI-22000587;
CC       O60333-2; O95872: GPANK1; NbExp=3; IntAct=EBI-10975473, EBI-751540;
CC       O60333-2; Q7Z602: GPR141; NbExp=3; IntAct=EBI-10975473, EBI-21649723;
CC       O60333-2; Q9Y4H4: GPSM3; NbExp=3; IntAct=EBI-10975473, EBI-347538;
CC       O60333-2; Q6NXT2: H3-5; NbExp=3; IntAct=EBI-10975473, EBI-2868501;
CC       O60333-2; A8K0U2: hCG_2001421; NbExp=3; IntAct=EBI-10975473, EBI-25843825;
CC       O60333-2; A0A024R1L7: hCG_41307; NbExp=3; IntAct=EBI-10975473, EBI-25849938;
CC       O60333-2; P49639: HOXA1; NbExp=3; IntAct=EBI-10975473, EBI-740785;
CC       O60333-2; P09017: HOXC4; NbExp=3; IntAct=EBI-10975473, EBI-3923226;
CC       O60333-2; Q96EW2-2: HSPBAP1; NbExp=3; IntAct=EBI-10975473, EBI-25835621;
CC       O60333-2; Q8IY31-3: IFT20; NbExp=3; IntAct=EBI-10975473, EBI-9091197;
CC       O60333-2; P22692: IGFBP4; NbExp=3; IntAct=EBI-10975473, EBI-2831948;
CC       O60333-2; Q14005-2: IL16; NbExp=3; IntAct=EBI-10975473, EBI-17178971;
CC       O60333-2; Q9NXX0: ILF3; NbExp=3; IntAct=EBI-10975473, EBI-743980;
CC       O60333-2; Q8WYH8-2: ING5; NbExp=3; IntAct=EBI-10975473, EBI-21602071;
CC       O60333-2; Q8IXL9: IQCF2; NbExp=3; IntAct=EBI-10975473, EBI-10238842;
CC       O60333-2; Q8NA54: IQUB; NbExp=3; IntAct=EBI-10975473, EBI-10220600;
CC       O60333-2; Q86U28: ISCA2; NbExp=3; IntAct=EBI-10975473, EBI-10258659;
CC       O60333-2; Q9UKP3-2: ITGB1BP2; NbExp=3; IntAct=EBI-10975473, EBI-25856470;
CC       O60333-2; P0C870: JMJD7; NbExp=3; IntAct=EBI-10975473, EBI-9090173;
CC       O60333-2; Q9NVX7-2: KBTBD4; NbExp=3; IntAct=EBI-10975473, EBI-25871195;
CC       O60333-2; Q8WZ19: KCTD13; NbExp=3; IntAct=EBI-10975473, EBI-742916;
CC       O60333-2; Q96SI1-2: KCTD15; NbExp=3; IntAct=EBI-10975473, EBI-12382297;
CC       O60333-2; Q06136: KDSR; NbExp=3; IntAct=EBI-10975473, EBI-3909166;
CC       O60333-2; Q6ZU52: KIAA0408; NbExp=3; IntAct=EBI-10975473, EBI-739493;
CC       O60333-2; Q12756: KIF1A; NbExp=3; IntAct=EBI-10975473, EBI-2679809;
CC       O60333-2; Q9UIH9: KLF15; NbExp=3; IntAct=EBI-10975473, EBI-2796400;
CC       O60333-2; P57682: KLF3; NbExp=3; IntAct=EBI-10975473, EBI-8472267;
CC       O60333-2; Q9Y2M5: KLHL20; NbExp=3; IntAct=EBI-10975473, EBI-714379;
CC       O60333-2; Q8N1A0: KRT222; NbExp=3; IntAct=EBI-10975473, EBI-8473062;
CC       O60333-2; Q14525: KRT33B; NbExp=3; IntAct=EBI-10975473, EBI-1049638;
CC       O60333-2; Q3SY46: KRTAP13-3; NbExp=3; IntAct=EBI-10975473, EBI-10241252;
CC       O60333-2; Q3SYF9: KRTAP19-7; NbExp=3; IntAct=EBI-10975473, EBI-10241353;
CC       O60333-2; Q8IUC2: KRTAP8-1; NbExp=3; IntAct=EBI-10975473, EBI-10261141;
CC       O60333-2; Q14847-2: LASP1; NbExp=3; IntAct=EBI-10975473, EBI-9088686;
CC       O60333-2; O95447: LCA5L; NbExp=3; IntAct=EBI-10975473, EBI-8473670;
CC       O60333-2; Q5T7P3: LCE1B; NbExp=3; IntAct=EBI-10975473, EBI-10245913;
CC       O60333-2; Q96PV6: LENG8; NbExp=3; IntAct=EBI-10975473, EBI-739546;
CC       O60333-2; Q68G74: LHX8; NbExp=3; IntAct=EBI-10975473, EBI-8474075;
CC       O60333-2; Q8N448: LNX2; NbExp=3; IntAct=EBI-10975473, EBI-2340947;
CC       O60333-2; A2RU56: LOC401296; NbExp=3; IntAct=EBI-10975473, EBI-9088215;
CC       O60333-2; Q96JB6: LOXL4; NbExp=3; IntAct=EBI-10975473, EBI-749562;
CC       O60333-2; Q14693: LPIN1; NbExp=3; IntAct=EBI-10975473, EBI-5278370;
CC       O60333-2; Q9UDY8-2: MALT1; NbExp=3; IntAct=EBI-10975473, EBI-12056869;
CC       O60333-2; Q99683: MAP3K5; NbExp=3; IntAct=EBI-10975473, EBI-476263;
CC       O60333-2; P61244-4: MAX; NbExp=3; IntAct=EBI-10975473, EBI-25848049;
CC       O60333-2; Q9NS73-5: MBIP; NbExp=3; IntAct=EBI-10975473, EBI-10182361;
CC       O60333-2; Q03112-9: MECOM; NbExp=3; IntAct=EBI-10975473, EBI-23820194;
CC       O60333-2; Q8N6F8: METTL27; NbExp=3; IntAct=EBI-10975473, EBI-8487781;
CC       O60333-2; Q9NYP9: MIS18A; NbExp=3; IntAct=EBI-10975473, EBI-1104552;
CC       O60333-2; Q15049: MLC1; NbExp=3; IntAct=EBI-10975473, EBI-8475277;
CC       O60333-2; A0A0A0MR05: MLST8; NbExp=3; IntAct=EBI-10975473, EBI-25835557;
CC       O60333-2; Q8N594: MPND; NbExp=3; IntAct=EBI-10975473, EBI-2512452;
CC       O60333-2; Q9Y605: MRFAP1; NbExp=3; IntAct=EBI-10975473, EBI-995714;
CC       O60333-2; Q96HT8: MRFAP1L1; NbExp=3; IntAct=EBI-10975473, EBI-748896;
CC       O60333-2; Q8IXL7-2: MSRB3; NbExp=3; IntAct=EBI-10975473, EBI-10699187;
CC       O60333-2; Q9NPC7: MYNN; NbExp=3; IntAct=EBI-10975473, EBI-3446748;
CC       O60333-2; P28331-5: NDUFS1; NbExp=3; IntAct=EBI-10975473, EBI-25876328;
CC       O60333-2; O76041: NEBL; NbExp=3; IntAct=EBI-10975473, EBI-2880203;
CC       O60333-2; I6L9F6: NEFL; NbExp=3; IntAct=EBI-10975473, EBI-10178578;
CC       O60333-2; Q8N5V2: NGEF; NbExp=3; IntAct=EBI-10975473, EBI-718372;
CC       O60333-2; Q8NBF2-2: NHLRC2; NbExp=3; IntAct=EBI-10975473, EBI-10697320;
CC       O60333-2; Q14995: NR1D2; NbExp=3; IntAct=EBI-10975473, EBI-6144053;
CC       O60333-2; Q96MF7: NSMCE2; NbExp=3; IntAct=EBI-10975473, EBI-2557388;
CC       O60333-2; Q6X4W1-6: NSMF; NbExp=3; IntAct=EBI-10975473, EBI-25842707;
CC       O60333-2; P36639-4: NUDT1; NbExp=3; IntAct=EBI-10975473, EBI-25834643;
CC       O60333-2; Q7Z417: NUFIP2; NbExp=3; IntAct=EBI-10975473, EBI-1210753;
CC       O60333-2; O15381-5: NVL; NbExp=3; IntAct=EBI-10975473, EBI-18577082;
CC       O60333-2; Q5BJF6-2: ODF2; NbExp=3; IntAct=EBI-10975473, EBI-9090919;
CC       O60333-2; O43482: OIP5; NbExp=3; IntAct=EBI-10975473, EBI-536879;
CC       O60333-2; Q96FW1: OTUB1; NbExp=3; IntAct=EBI-10975473, EBI-1058491;
CC       O60333-2; Q6GQQ9-2: OTUD7B; NbExp=3; IntAct=EBI-10975473, EBI-25830200;
CC       O60333-2; Q9NR21-5: PARP11; NbExp=3; IntAct=EBI-10975473, EBI-17159452;
CC       O60333-2; Q9HBE1-4: PATZ1; NbExp=3; IntAct=EBI-10975473, EBI-11022007;
CC       O60333-2; P22061-2: PCMT1; NbExp=3; IntAct=EBI-10975473, EBI-12386584;
CC       O60333-2; Q9NV79: PCMTD2; NbExp=3; IntAct=EBI-10975473, EBI-6309018;
CC       O60333-2; Q9BRX2: PELO; NbExp=3; IntAct=EBI-10975473, EBI-1043580;
CC       O60333-2; O15534: PER1; NbExp=3; IntAct=EBI-10975473, EBI-2557276;
CC       O60333-2; Q96FX8: PERP; NbExp=3; IntAct=EBI-10975473, EBI-17183069;
CC       O60333-2; Q96LB9: PGLYRP3; NbExp=3; IntAct=EBI-10975473, EBI-12339509;
CC       O60333-2; Q7RTV0: PHF5A; NbExp=3; IntAct=EBI-10975473, EBI-2555365;
CC       O60333-2; O75925: PIAS1; NbExp=3; IntAct=EBI-10975473, EBI-629434;
CC       O60333-2; Q9UF11-2: PLEKHB1; NbExp=3; IntAct=EBI-10975473, EBI-12832742;
CC       O60333-2; Q58EX7-2: PLEKHG4; NbExp=3; IntAct=EBI-10975473, EBI-21503705;
CC       O60333-2; Q99541: PLIN2; NbExp=3; IntAct=EBI-10975473, EBI-2115275;
CC       O60333-2; Q8TBJ4: PLPPR1; NbExp=3; IntAct=EBI-10975473, EBI-18063495;
CC       O60333-2; Q8NA72-3: POC5; NbExp=3; IntAct=EBI-10975473, EBI-11751537;
CC       O60333-2; Q9H1D9: POLR3F; NbExp=3; IntAct=EBI-10975473, EBI-710067;
CC       O60333-2; O43741: PRKAB2; NbExp=3; IntAct=EBI-10975473, EBI-1053424;
CC       O60333-2; P60891: PRPS1; NbExp=3; IntAct=EBI-10975473, EBI-749195;
CC       O60333-2; P11908: PRPS2; NbExp=3; IntAct=EBI-10975473, EBI-4290895;
CC       O60333-2; P28062-2: PSMB8; NbExp=3; IntAct=EBI-10975473, EBI-372312;
CC       O60333-2; P47897: QARS1; NbExp=3; IntAct=EBI-10975473, EBI-347462;
CC       O60333-2; Q9Y5P3: RAI2; NbExp=3; IntAct=EBI-10975473, EBI-746228;
CC       O60333-2; Q96PK6: RBM14; NbExp=3; IntAct=EBI-10975473, EBI-954272;
CC       O60333-2; Q9P2K3-2: RCOR3; NbExp=3; IntAct=EBI-10975473, EBI-1504830;
CC       O60333-2; Q6NTF9-3: RHBDD2; NbExp=3; IntAct=EBI-10975473, EBI-17589229;
CC       O60333-2; Q8TDP1: RNASEH2C; NbExp=3; IntAct=EBI-10975473, EBI-9027335;
CC       O60333-2; Q8N5U6: RNF10; NbExp=3; IntAct=EBI-10975473, EBI-714023;
CC       O60333-2; Q8WVD3: RNF138; NbExp=3; IntAct=EBI-10975473, EBI-749039;
CC       O60333-2; Q96D59: RNF183; NbExp=3; IntAct=EBI-10975473, EBI-743938;
CC       O60333-2; Q9H0X6: RNF208; NbExp=3; IntAct=EBI-10975473, EBI-751555;
CC       O60333-2; P62244: RPS15A; NbExp=3; IntAct=EBI-10975473, EBI-347895;
CC       O60333-2; P08865: RPSA; NbExp=3; IntAct=EBI-10975473, EBI-354112;
CC       O60333-2; Q66K80: RUSC1-AS1; NbExp=3; IntAct=EBI-10975473, EBI-10248967;
CC       O60333-2; Q8N488: RYBP; NbExp=3; IntAct=EBI-10975473, EBI-752324;
CC       O60333-2; Q8N6K7-2: SAMD3; NbExp=3; IntAct=EBI-10975473, EBI-11528848;
CC       O60333-2; Q7Z3H4: SAMD7; NbExp=3; IntAct=EBI-10975473, EBI-12148649;
CC       O60333-2; P34741: SDC2; NbExp=3; IntAct=EBI-10975473, EBI-1172957;
CC       O60333-2; O00560: SDCBP; NbExp=3; IntAct=EBI-10975473, EBI-727004;
CC       O60333-2; Q9NTN9-3: SEMA4G; NbExp=3; IntAct=EBI-10975473, EBI-9089805;
CC       O60333-2; Q96B97: SH3KBP1; NbExp=3; IntAct=EBI-10975473, EBI-346595;
CC       O60333-2; Q9NUL5-3: SHFL; NbExp=3; IntAct=EBI-10975473, EBI-22000547;
CC       O60333-2; Q8IYI0: SHLD1; NbExp=3; IntAct=EBI-10975473, EBI-2560428;
CC       O60333-2; O60902-3: SHOX2; NbExp=3; IntAct=EBI-10975473, EBI-9092164;
CC       O60333-2; P12757: SKIL; NbExp=3; IntAct=EBI-10975473, EBI-2902468;
CC       O60333-2; P08195-4: SLC3A2; NbExp=3; IntAct=EBI-10975473, EBI-12832276;
CC       O60333-2; Q9NSD5-3: SLC6A13; NbExp=3; IntAct=EBI-10975473, EBI-25831241;
CC       O60333-2; Q92966: SNAPC3; NbExp=3; IntAct=EBI-10975473, EBI-1760638;
CC       O60333-2; Q13573: SNW1; NbExp=3; IntAct=EBI-10975473, EBI-632715;
CC       O60333-2; Q99932-2: SPAG8; NbExp=3; IntAct=EBI-10975473, EBI-11959123;
CC       O60333-2; A0A024R4B0: SPATA3; NbExp=3; IntAct=EBI-10975473, EBI-14123856;
CC       O60333-2; Q8TCT7-2: SPPL2B; NbExp=3; IntAct=EBI-10975473, EBI-8345366;
CC       O60333-2; Q7Z698: SPRED2; NbExp=3; IntAct=EBI-10975473, EBI-7082156;
CC       O60333-2; Q9C004: SPRY4; NbExp=3; IntAct=EBI-10975473, EBI-354861;
CC       O60333-2; Q99619: SPSB2; NbExp=3; IntAct=EBI-10975473, EBI-2323209;
CC       O60333-2; Q8IXS7: SRGAP3; NbExp=3; IntAct=EBI-10975473, EBI-18616594;
CC       O60333-2; O75886: STAM2; NbExp=3; IntAct=EBI-10975473, EBI-373258;
CC       O60333-2; Q8NBJ7: SUMF2; NbExp=3; IntAct=EBI-10975473, EBI-723091;
CC       O60333-2; Q9H7C4: SYNC; NbExp=3; IntAct=EBI-10975473, EBI-11285923;
CC       O60333-2; Q17RD7-3: SYT16; NbExp=3; IntAct=EBI-10975473, EBI-25861603;
CC       O60333-2; Q86TJ2-3: TADA2B; NbExp=3; IntAct=EBI-10975473, EBI-18173581;
CC       O60333-2; Q5VWN6: TASOR2; NbExp=3; IntAct=EBI-10975473, EBI-745958;
CC       O60333-2; Q8IYN2: TCEAL8; NbExp=3; IntAct=EBI-10975473, EBI-2116184;
CC       O60333-2; Q9BQ70: TCF25; NbExp=3; IntAct=EBI-10975473, EBI-745182;
CC       O60333-2; Q13569: TDG; NbExp=3; IntAct=EBI-10975473, EBI-348333;
CC       O60333-2; Q86WV5: TEN1; NbExp=3; IntAct=EBI-10975473, EBI-2562799;
CC       O60333-2; Q96A09: TENT5B; NbExp=3; IntAct=EBI-10975473, EBI-752030;
CC       O60333-2; Q8NA77: TEX19; NbExp=3; IntAct=EBI-10975473, EBI-13323487;
CC       O60333-2; P21980-2: TGM2; NbExp=3; IntAct=EBI-10975473, EBI-25842075;
CC       O60333-2; O60830: TIMM17B; NbExp=3; IntAct=EBI-10975473, EBI-2372529;
CC       O60333-2; Q8N0U2: TMEM61; NbExp=3; IntAct=EBI-10975473, EBI-25830583;
CC       O60333-2; Q8IUR5-4: TMTC1; NbExp=3; IntAct=EBI-10975473, EBI-9089156;
CC       O60333-2; Q71RG4-4: TMUB2; NbExp=3; IntAct=EBI-10975473, EBI-25831574;
CC       O60333-2; P36406: TRIM23; NbExp=3; IntAct=EBI-10975473, EBI-740098;
CC       O60333-2; Q9UPQ4-2: TRIM35; NbExp=3; IntAct=EBI-10975473, EBI-17716262;
CC       O60333-2; L8E9Q5: TRIM65; NbExp=3; IntAct=EBI-10975473, EBI-25843781;
CC       O60333-2; Q86WT6-2: TRIM69; NbExp=3; IntAct=EBI-10975473, EBI-11525489;
CC       O60333-2; Q9C026: TRIM9; NbExp=3; IntAct=EBI-10975473, EBI-720828;
CC       O60333-2; Q86WV8: TSC1; NbExp=3; IntAct=EBI-10975473, EBI-12806590;
CC       O60333-2; Q9Y3Q8: TSC22D4; NbExp=3; IntAct=EBI-10975473, EBI-739485;
CC       O60333-2; Q9BUF5: TUBB6; NbExp=3; IntAct=EBI-10975473, EBI-356735;
CC       O60333-2; Q9UGJ1-2: TUBGCP4; NbExp=3; IntAct=EBI-10975473, EBI-10964469;
CC       O60333-2; Q5VYS8-5: TUT7; NbExp=3; IntAct=EBI-10975473, EBI-9088812;
CC       O60333-2; Q9BSL1: UBAC1; NbExp=3; IntAct=EBI-10975473, EBI-749370;
CC       O60333-2; Q8NBM4-4: UBAC2; NbExp=3; IntAct=EBI-10975473, EBI-25840976;
CC       O60333-2; Q969T4: UBE2E3; NbExp=3; IntAct=EBI-10975473, EBI-348496;
CC       O60333-2; Q13404: UBE2V1; NbExp=3; IntAct=EBI-10975473, EBI-1050671;
CC       O60333-2; Q04323-2: UBXN1; NbExp=3; IntAct=EBI-10975473, EBI-11530712;
CC       O60333-2; O75604-3: USP2; NbExp=3; IntAct=EBI-10975473, EBI-10696113;
CC       O60333-2; P45880: VDAC2; NbExp=3; IntAct=EBI-10975473, EBI-354022;
CC       O60333-2; P40337-2: VHL; NbExp=3; IntAct=EBI-10975473, EBI-12157263;
CC       O60333-2; Q8NEZ2: VPS37A; NbExp=3; IntAct=EBI-10975473, EBI-2850578;
CC       O60333-2; P58304: VSX2; NbExp=3; IntAct=EBI-10975473, EBI-6427899;
CC       O60333-2; Q9BQA1: WDR77; NbExp=3; IntAct=EBI-10975473, EBI-1237307;
CC       O60333-2; Q9BRX9: WDR83; NbExp=3; IntAct=EBI-10975473, EBI-7705033;
CC       O60333-2; Q15007-2: WTAP; NbExp=3; IntAct=EBI-10975473, EBI-25840023;
CC       O60333-2; Q9NZC7-5: WWOX; NbExp=3; IntAct=EBI-10975473, EBI-12040603;
CC       O60333-2; O43167-2: ZBTB24; NbExp=3; IntAct=EBI-10975473, EBI-25842419;
CC       O60333-2; Q53FD0-2: ZC2HC1C; NbExp=3; IntAct=EBI-10975473, EBI-14104088;
CC       O60333-2; Q15776: ZKSCAN8; NbExp=3; IntAct=EBI-10975473, EBI-2602314;
CC       O60333-2; Q9UJW8-4: ZNF180; NbExp=3; IntAct=EBI-10975473, EBI-12055755;
CC       O60333-2; Q8N895: ZNF366; NbExp=3; IntAct=EBI-10975473, EBI-2813661;
CC       O60333-2; Q9C0F3: ZNF436; NbExp=3; IntAct=EBI-10975473, EBI-8489702;
CC       O60333-2; Q8N0Y2-2: ZNF444; NbExp=3; IntAct=EBI-10975473, EBI-12010736;
CC       O60333-2; Q96MN9-2: ZNF488; NbExp=3; IntAct=EBI-10975473, EBI-25831733;
CC       O60333-2; Q6ZNH5: ZNF497; NbExp=3; IntAct=EBI-10975473, EBI-10486136;
CC       O60333-2; Q96C55: ZNF524; NbExp=3; IntAct=EBI-10975473, EBI-10283126;
CC       O60333-2; Q68EA5: ZNF57; NbExp=3; IntAct=EBI-10975473, EBI-8490788;
CC       O60333-2; Q7Z3I7: ZNF572; NbExp=3; IntAct=EBI-10975473, EBI-10172590;
CC       O60333-2; Q96N77-2: ZNF641; NbExp=3; IntAct=EBI-10975473, EBI-12939666;
CC       O60333-2; Q9BS34: ZNF670; NbExp=3; IntAct=EBI-10975473, EBI-745276;
CC       O60333-2; Q3KNS6-3: ZNF829; NbExp=3; IntAct=EBI-10975473, EBI-18036029;
CC       O60333-2; Q15695: ZRSR2P1; NbExp=3; IntAct=EBI-10975473, EBI-12270264;
CC       O60333-2; O15535: ZSCAN9; NbExp=3; IntAct=EBI-10975473, EBI-751531;
CC       O60333-2; Q2QGD7: ZXDC; NbExp=3; IntAct=EBI-10975473, EBI-1538838;
CC       O60333-2; A0A384ME25; NbExp=3; IntAct=EBI-10975473, EBI-10211777;
CC       O60333-2; B4DLR9; NbExp=3; IntAct=EBI-10975473, EBI-25851268;
CC       O60333-2; B7Z3E8; NbExp=3; IntAct=EBI-10975473, EBI-25831617;
CC       O60333-2; Q7L8T7; NbExp=3; IntAct=EBI-10975473, EBI-25831943;
CC       O60333-2; Q7Z783; NbExp=3; IntAct=EBI-10975473, EBI-9088990;
CC       O60333-2; Q86V28; NbExp=3; IntAct=EBI-10975473, EBI-10259496;
CC       O60333-3; Q12959: DLG1; NbExp=4; IntAct=EBI-465669, EBI-357481;
CC       O60333-3; P78352: DLG4; NbExp=4; IntAct=EBI-465669, EBI-80389;
CC       O60333-3; Q96QZ7: MAGI1; NbExp=3; IntAct=EBI-465669, EBI-924464;
CC       O60333-3; Q63622: Dlg2; Xeno; NbExp=3; IntAct=EBI-465669, EBI-396947;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton. Mitochondrion
CC       {ECO:0000269|PubMed:16225668}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Cytoplasmic vesicle, secretory
CC       vesicle, synaptic vesicle {ECO:0000250|UniProtKB:O88658}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=O60333-1; Sequence=Displayed;
CC       Name=2; Synonyms=Beta;
CC         IsoId=O60333-2; Sequence=VSP_002858, VSP_002859;
CC       Name=3; Synonyms=Alpha;
CC         IsoId=O60333-3; Sequence=VSP_002858, VSP_002859, VSP_002860,
CC                                  VSP_002861;
CC       Name=4;
CC         IsoId=O60333-4; Sequence=VSP_009381;
CC   -!- TISSUE SPECIFICITY: Isoform 3 is abundant in the skeletal muscle. It is
CC       also expressed in fetal brain, lung and kidney, and adult heart,
CC       placenta, testis, ovary and small intestine. Isoform 2 is abundant in
CC       the brain and also expressed in fetal heart, lung, liver and kidney,
CC       and adult skeletal muscle, placenta, liver, kidney, heart, spleen,
CC       thymus, prostate, testis, ovary, small intestine, colon and pancreas.
CC       {ECO:0000269|PubMed:10762626, ECO:0000269|PubMed:11526494,
CC       ECO:0000269|PubMed:12888911}.
CC   -!- DISEASE: Charcot-Marie-Tooth disease 2A1 (CMT2A1) [MIM:118210]: A
CC       dominant axonal form of Charcot-Marie-Tooth disease, a disorder of the
CC       peripheral nervous system, characterized by progressive weakness and
CC       atrophy, initially of the peroneal muscles and later of the distal
CC       muscles of the arms. Charcot-Marie-Tooth disease is classified in two
CC       main groups on the basis of electrophysiologic properties and
CC       histopathology: primary peripheral demyelinating neuropathies
CC       (designated CMT1 when they are dominantly inherited) and primary
CC       peripheral axonal neuropathies (CMT2). Neuropathies of the CMT2 group
CC       are characterized by signs of axonal degeneration in the absence of
CC       obvious myelin alterations, normal or slightly reduced nerve conduction
CC       velocities, and progressive distal muscle weakness and atrophy.
CC       {ECO:0000269|PubMed:11389829}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Neuroblastoma 1 (NBLST1) [MIM:256700]: A common neoplasm of
CC       early childhood arising from embryonic cells that form the primitive
CC       neural crest and give rise to the adrenal medulla and the sympathetic
CC       nervous system. Note=Disease susceptibility is associated with variants
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Pheochromocytoma (PCC) [MIM:171300]: A catecholamine-producing
CC       tumor of chromaffin tissue of the adrenal medulla or sympathetic
CC       paraganglia. The cardinal symptom, reflecting the increased secretion
CC       of epinephrine and norepinephrine, is hypertension, which may be
CC       persistent or intermittent. {ECO:0000269|PubMed:18334619}. Note=Disease
CC       susceptibility is associated with variants affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the TRAFAC class myosin-kinesin ATPase
CC       superfamily. Kinesin family. Unc-104 subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00283}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH01415.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAP35838.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAA25517.2; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAA95972.2; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAB69038.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Inherited peripheral neuropathies mutation db;
CC       URL="https://uantwerpen.vib.be/CMTMutations";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AX039604; CAC16629.1; -; Genomic_DNA.
DR   EMBL; AB017133; BAB69038.1; ALT_INIT; mRNA.
DR   EMBL; AF257176; AAK49332.1; -; mRNA.
DR   EMBL; AY043362; AAK85155.1; -; mRNA.
DR   EMBL; AB088210; BAE02543.1; -; mRNA.
DR   EMBL; AY139835; AAN17742.1; -; mRNA.
DR   EMBL; AB011163; BAA25517.2; ALT_INIT; mRNA.
DR   EMBL; AB040881; BAA95972.2; ALT_INIT; mRNA.
DR   EMBL; AL139424; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL358013; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC001415; AAH01415.1; ALT_INIT; mRNA.
DR   EMBL; BC115395; AAI15396.1; -; mRNA.
DR   EMBL; BT007174; AAP35838.1; ALT_INIT; mRNA.
DR   EMBL; AK022977; BAB14341.1; -; mRNA.
DR   CCDS; CCDS111.1; -. [O60333-2]
DR   CCDS; CCDS112.1; -. [O60333-3]
DR   RefSeq; NP_055889.2; NM_015074.3. [O60333-2]
DR   RefSeq; NP_904325.2; NM_183416.3. [O60333-3]
DR   PDB; 2EH0; NMR; -; A=531-647.
DR   PDBsum; 2EH0; -.
DR   SMR; O60333; -.
DR   BioGRID; 116723; 113.
DR   DIP; DIP-33015N; -.
DR   IntAct; O60333; 336.
DR   MINT; O60333; -.
DR   STRING; 9606.ENSP00000263934; -.
DR   BindingDB; O60333; -.
DR   ChEMBL; CHEMBL5889; -.
DR   iPTMnet; O60333; -.
DR   MetOSite; O60333; -.
DR   PhosphoSitePlus; O60333; -.
DR   SwissPalm; O60333; -.
DR   BioMuta; KIF1B; -.
DR   EPD; O60333; -.
DR   jPOST; O60333; -.
DR   MassIVE; O60333; -.
DR   MaxQB; O60333; -.
DR   PaxDb; O60333; -.
DR   PeptideAtlas; O60333; -.
DR   PRIDE; O60333; -.
DR   ProteomicsDB; 49353; -. [O60333-1]
DR   ProteomicsDB; 49354; -. [O60333-2]
DR   ProteomicsDB; 49355; -. [O60333-3]
DR   ProteomicsDB; 49356; -. [O60333-4]
DR   Antibodypedia; 4196; 108 antibodies.
DR   DNASU; 23095; -.
DR   Ensembl; ENST00000263934; ENSP00000263934; ENSG00000054523. [O60333-2]
DR   Ensembl; ENST00000377081; ENSP00000366284; ENSG00000054523. [O60333-4]
DR   Ensembl; ENST00000377083; ENSP00000366287; ENSG00000054523. [O60333-3]
DR   Ensembl; ENST00000377086; ENSP00000366290; ENSG00000054523. [O60333-1]
DR   Ensembl; ENST00000377093; ENSP00000366297; ENSG00000054523. [O60333-3]
DR   Ensembl; ENST00000676179; ENSP00000502065; ENSG00000054523. [O60333-1]
DR   GeneID; 23095; -.
DR   KEGG; hsa:23095; -.
DR   UCSC; uc001aqv.5; human. [O60333-1]
DR   CTD; 23095; -.
DR   DisGeNET; 23095; -.
DR   GeneCards; KIF1B; -.
DR   GeneReviews; KIF1B; -.
DR   HGNC; HGNC:16636; KIF1B.
DR   HPA; ENSG00000054523; Tissue enhanced (skeletal).
DR   MalaCards; KIF1B; -.
DR   MIM; 118210; phenotype.
DR   MIM; 171300; phenotype.
DR   MIM; 256700; phenotype.
DR   MIM; 605995; gene.
DR   neXtProt; NX_O60333; -.
DR   OpenTargets; ENSG00000054523; -.
DR   Orphanet; 99946; Autosomal dominant Charcot-Marie-Tooth disease type 2A1.
DR   Orphanet; 29072; Hereditary pheochromocytoma-paraganglioma.
DR   PharmGKB; PA38176; -.
DR   VEuPathDB; HostDB:ENSG00000054523.17; -.
DR   eggNOG; KOG0245; Eukaryota.
DR   GeneTree; ENSGT00940000157445; -.
DR   HOGENOM; CLU_009645_0_0_1; -.
DR   InParanoid; O60333; -.
DR   OMA; LHQEDEF; -.
DR   OrthoDB; 76316at2759; -.
DR   PhylomeDB; O60333; -.
DR   TreeFam; TF105221; -.
DR   PathwayCommons; O60333; -.
DR   Reactome; R-HSA-6811434; COPI-dependent Golgi-to-ER retrograde traffic.
DR   Reactome; R-HSA-983189; Kinesins.
DR   BioGRID-ORCS; 23095; 4 hits in 992 CRISPR screens.
DR   ChiTaRS; KIF1B; human.
DR   EvolutionaryTrace; O60333; -.
DR   GeneWiki; KIF1B; -.
DR   GenomeRNAi; 23095; -.
DR   Pharos; O60333; Tbio.
DR   PRO; PR:O60333; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; O60333; protein.
DR   Bgee; ENSG00000054523; Expressed in skeletal muscle tissue of rectus abdominis and 235 other tissues.
DR   ExpressionAtlas; O60333; baseline and differential.
DR   Genevisible; O60333; HS.
DR   GO; GO:0030424; C:axon; IBA:GO_Central.
DR   GO; GO:1904115; C:axon cytoplasm; IEA:GOC.
DR   GO; GO:0031410; C:cytoplasmic vesicle; ISS:UniProtKB.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; ISS:UniProtKB.
DR   GO; GO:0030425; C:dendrite; IBA:GO_Central.
DR   GO; GO:0005871; C:kinesin complex; IBA:GO_Central.
DR   GO; GO:0005874; C:microtubule; IBA:GO_Central.
DR   GO; GO:0005875; C:microtubule associated complex; ISS:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IEA:UniProtKB-SubCell.
DR   GO; GO:0043005; C:neuron projection; ISS:UniProtKB.
DR   GO; GO:0008021; C:synaptic vesicle; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0008574; F:ATP-dependent microtubule motor activity, plus-end-directed; IBA:GO_Central.
DR   GO; GO:0016887; F:ATPase activity; ISS:UniProtKB.
DR   GO; GO:0019900; F:kinase binding; IEA:Ensembl.
DR   GO; GO:0019894; F:kinesin binding; TAS:UniProtKB.
DR   GO; GO:0008017; F:microtubule binding; IBA:GO_Central.
DR   GO; GO:0003777; F:microtubule motor activity; ISS:UniProtKB.
DR   GO; GO:0097110; F:scaffold protein binding; IEA:Ensembl.
DR   GO; GO:0008089; P:anterograde axonal transport; ISS:UniProtKB.
DR   GO; GO:1990048; P:anterograde neuronal dense core vesicle transport; IEA:Ensembl.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:1990090; P:cellular response to nerve growth factor stimulus; IEA:Ensembl.
DR   GO; GO:0030705; P:cytoskeleton-dependent intracellular transport; ISS:UniProtKB.
DR   GO; GO:0032418; P:lysosome localization; IEA:Ensembl.
DR   GO; GO:0007018; P:microtubule-based movement; ISS:UniProtKB.
DR   GO; GO:0007274; P:neuromuscular synaptic transmission; ISS:UniProtKB.
DR   GO; GO:0007270; P:neuron-neuron synaptic transmission; ISS:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; IEA:Ensembl.
DR   GO; GO:1990778; P:protein localization to cell periphery; IEA:Ensembl.
DR   GO; GO:1904647; P:response to rotenone; IEA:Ensembl.
DR   GO; GO:1990049; P:retrograde neuronal dense core vesicle transport; IEA:Ensembl.
DR   GO; GO:0016192; P:vesicle-mediated transport; IBA:GO_Central.
DR   CDD; cd00060; FHA; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   Gene3D; 3.40.850.10; -; 1.
DR   InterPro; IPR000253; FHA_dom.
DR   InterPro; IPR022164; Kinesin-like.
DR   InterPro; IPR027640; Kinesin-like_fam.
DR   InterPro; IPR022140; Kinesin-like_KIF1-typ.
DR   InterPro; IPR032405; Kinesin_assoc.
DR   InterPro; IPR019821; Kinesin_motor_CS.
DR   InterPro; IPR001752; Kinesin_motor_dom.
DR   InterPro; IPR036961; Kinesin_motor_dom_sf.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR008984; SMAD_FHA_dom_sf.
DR   PANTHER; PTHR24115; PTHR24115; 1.
DR   Pfam; PF12473; DUF3694; 1.
DR   Pfam; PF00498; FHA; 1.
DR   Pfam; PF12423; KIF1B; 1.
DR   Pfam; PF00225; Kinesin; 1.
DR   Pfam; PF16183; Kinesin_assoc; 1.
DR   Pfam; PF00169; PH; 1.
DR   PRINTS; PR00380; KINESINHEAVY.
DR   SMART; SM00240; FHA; 1.
DR   SMART; SM00129; KISc; 1.
DR   SMART; SM00233; PH; 1.
DR   SUPFAM; SSF49879; SSF49879; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS50006; FHA_DOMAIN; 1.
DR   PROSITE; PS00411; KINESIN_MOTOR_1; 1.
DR   PROSITE; PS50067; KINESIN_MOTOR_2; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Apoptosis; ATP-binding;
KW   Cell junction; Charcot-Marie-Tooth disease; Coiled coil; Cytoplasm;
KW   Cytoplasmic vesicle; Cytoskeleton; Disease variant; Microtubule;
KW   Mitochondrion; Motor protein; Neurodegeneration; Neuropathy;
KW   Nucleotide-binding; Phosphoprotein; Reference proteome; Synapse.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0007744|PubMed:22814378"
FT   CHAIN           2..1816
FT                   /note="Kinesin-like protein KIF1B"
FT                   /id="PRO_0000125407"
FT   DOMAIN          5..354
FT                   /note="Kinesin motor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00283"
FT   DOMAIN          556..612
FT                   /note="FHA"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00086"
FT   DOMAIN          1702..1799
FT                   /note="PH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   NP_BIND         97..104
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00283"
FT   REGION          270..350
FT                   /note="Interaction with KBP"
FT                   /evidence="ECO:0000269|PubMed:16225668"
FT   COILED          365..386
FT                   /evidence="ECO:0000255"
FT   COILED          470..502
FT                   /evidence="ECO:0000255"
FT   COILED          668..737
FT                   /evidence="ECO:0000255"
FT   COILED          841..869
FT                   /evidence="ECO:0000255"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0007744|PubMed:22814378"
FT   MOD_RES         647
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q60575"
FT   MOD_RES         652
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q60575"
FT   MOD_RES         1054
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         1057
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:23186163"
FT   MOD_RES         1075
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:19690332"
FT   MOD_RES         1416
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         1454
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         1487
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:23186163"
FT   MOD_RES         1573
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         1603
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         1610
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         1613
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:24275569"
FT   VAR_SEQ         289..294
FT                   /note="Missing (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:10819331,
FT                   ECO:0000303|PubMed:12888911, ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|Ref.4"
FT                   /id="VSP_002858"
FT   VAR_SEQ         394..434
FT                   /note="IDPLIDDYSGSGSKYLKDFQNNKHRYLLASENQRPGHFSTA -> T (in
FT                   isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:10819331,
FT                   ECO:0000303|PubMed:12888911, ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|Ref.4"
FT                   /id="VSP_002859"
FT   VAR_SEQ         707..1196
FT                   /note="YESKLQALQKQVETRSLAAETTEEEEEEEEVPWTQHEFELAQWAFRKWKSHQ
FT                   FTSLRDLLWGNAVYLKEANAISVELKKKVQFQFVLLTDTLYSPLPPELLPTEMEKTHED
FT                   RPFPRTVVAVEVQDLKNGATHYWSLEKLKQRLDLMREMYDRAGEMASSAQDESETTVTG
FT                   SDPFYDRFHWFKLVGSSPIFHGCVNERLADRTPSPTFSTADSDITELADEQQDEMEDFD
FT                   DEAFVDDAGSDAGTEEGSDLFSDGHDPFYDRSPWFILVGRAFVYLSNLLYPVPLIHRVA
FT                   IVSEKGEVRGFLRVAVQAIAADEEAPDYGSGIRQSGTAKISFDNEYFNQSDFSSVAMTR
FT                   SGLSLEELRIVEGQGQSSEVITPPEEISRINDLDLKSSTLLDGKMVMEGFSEEIGNHLK
FT                   LGSAFTFRVTVLQASGILPEYADIFCQFNFLHRHDEAFSTEPLKNNGRGSPLAFYHVQN
FT                   IAVEITESFVDYIKTKPIVFEVFGH -> ADSDSGDDSDKRSCEESWKLITSLREKLPP
FT                   SKLQTIVKKCGLPSSGKKREPIKMYQIPQRRRLSKDSKWVTISDLKIQAVKEICYEVAL
FT                   NDFRHSRQEIEALAIVKMKELCAMYGKKDPNERDSWRAVARDVWDTVGVGDEKIEDVMA
FT                   TGKGSTDVDDLKVHIDKLEDILQEVKKQNNMKDEEIKVLRNKMLKMEKVLPLIGSQEQK
FT                   SPGSHKAKEPVGAGVSSTSENNVSKGDNGELAKEERVSQLMNGDPAFRRGRLRWMRQEQ
FT                   IRFKNLQQQEITKQLRRQNVPHRFIPPENRKPRFPFKSNPKHRNSWSPGTHIIITEDEV
FT                   IELRIPKDDEARKGNKEESQEKGGKGAFKDPQFPWGSQGMRSQDHIQVSKQHINNQQQP
FT                   PQLRWRSNSLNNGQPKSTRCQASASAESLNSHSGHPTADVQTFQAKRHIHQHRQSYCNY
FT                   NTGGQLEGNAATSYQKQTDKPSHCSQFVTPPRMRRQFSAPNLKAGRETTV (in
FT                   isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:10819331,
FT                   ECO:0000303|PubMed:12888911, ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|Ref.4"
FT                   /id="VSP_002860"
FT   VAR_SEQ         1197..1816
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:10819331,
FT                   ECO:0000303|PubMed:12888911, ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|Ref.4"
FT                   /id="VSP_002861"
FT   VAR_SEQ         1804..1816
FT                   /note="SKLSRRCPSQSKY -> PGHLASEIIREDKSVSFSCQ (in isoform
FT                   4)"
FT                   /evidence="ECO:0000303|PubMed:10762626, ECO:0000303|Ref.5"
FT                   /id="VSP_009381"
FT   VARIANT         34
FT                   /note="S -> L (in a medulloblastoma sample; somatic
FT                   mutation; loss of ability to induce apoptosis;
FT                   dbSNP:rs1269940164)"
FT                   /evidence="ECO:0000269|PubMed:18334619"
FT                   /id="VAR_063531"
FT   VARIANT         98
FT                   /note="Q -> L (in CMT2A1; dbSNP:rs121908160)"
FT                   /evidence="ECO:0000269|PubMed:11389829"
FT                   /id="VAR_011515"
FT   VARIANT         692
FT                   /note="E -> V (confers susceptibility to neuroblastoma;
FT                   found as germline mutation in a neuroblastoma patient; loss
FT                   of ability to induce apoptosis; dbSNP:rs121908161)"
FT                   /evidence="ECO:0000269|PubMed:18334619"
FT                   /id="VAR_063532"
FT   VARIANT         873
FT                   /note="T -> I (confers susceptibility to neuroblastoma;
FT                   found as germline mutation in a neuroblastoma patient; loss
FT                   of ability to induce apoptosis; dbSNP:rs121908162)"
FT                   /evidence="ECO:0000269|PubMed:18334619"
FT                   /id="VAR_063533"
FT   VARIANT         1133
FT                   /note="Y -> C (in dbSNP:rs2297881)"
FT                   /evidence="ECO:0000269|PubMed:18334619"
FT                   /id="VAR_063534"
FT   VARIANT         1263
FT                   /note="P -> S (confers susceptibility to neuroblastoma;
FT                   found as germline mutation in a neuroblastoma patient; loss
FT                   of ability to induce apoptosis; dbSNP:rs121908163)"
FT                   /evidence="ECO:0000269|PubMed:18334619"
FT                   /id="VAR_063535"
FT   VARIANT         1527
FT                   /note="S -> N (confers susceptibility to pheochromocytoma;
FT                   found as germline mutation in a pheochromocytoma family;
FT                   loss of ability to induce apoptosis; dbSNP:rs121908164)"
FT                   /evidence="ECO:0000269|PubMed:18334619"
FT                   /id="VAR_063536"
FT   VARIANT         1600
FT                   /note="V -> M (in dbSNP:rs77172218)"
FT                   /evidence="ECO:0000269|PubMed:18334619"
FT                   /id="VAR_063537"
FT   VARIANT         1674
FT                   /note="E -> K (in a pheochromocytoma sample; loss of
FT                   ability to induce apoptosis; dbSNP:rs143669846)"
FT                   /evidence="ECO:0000269|PubMed:18334619"
FT                   /id="VAR_063538"
FT   CONFLICT        87
FT                   /note="E -> G (in Ref. 8; BAA25517)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        129..131
FT                   /note="KIN -> TNH (in Ref. 3; AAK49332, 4; AAK85155 and 5;
FT                   AAN17742)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        170
FT                   /note="E -> D (in Ref. 3; AAK49332, 4; AAK85155 and 5;
FT                   AAN17742)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        174
FT                   /note="L -> R (in Ref. 3; AAK49332, 4; AAK85155 and 5;
FT                   AAN17742)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        219..221
FT                   /note="AVF -> VVY (in Ref. 3; AAK49332, 4; AAK85155 and 5;
FT                   AAN17742)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        235..239
FT                   /note="NLSTE -> ILATV (in Ref. 3; AAK49332, 4; AAK85155 and
FT                   5; AAN17742)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        244
FT                   /note="I -> T (in Ref. 3; AAK49332, 4; AAK85155 and 5;
FT                   AAN17742)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        253
FT                   /note="E -> D (in Ref. 3; AAK49332, 4; AAK85155 and 5;
FT                   AAN17742)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        256
FT                   /note="D -> A (in Ref. 3; AAK49332, 4; AAK85155 and 5;
FT                   AAN17742)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        270
FT                   /note="N -> I (in Ref. 3; AAK49332, 4; AAK85155 and 5;
FT                   AAN17742)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        363
FT                   /note="D -> G (in Ref. 2; BAB69038)"
FT                   /evidence="ECO:0000305"
FT   STRAND          533..535
FT                   /evidence="ECO:0007744|PDB:2EH0"
FT   STRAND          547..550
FT                   /evidence="ECO:0007744|PDB:2EH0"
FT   STRAND          553..559
FT                   /evidence="ECO:0007744|PDB:2EH0"
FT   STRAND          563..565
FT                   /evidence="ECO:0007744|PDB:2EH0"
FT   STRAND          568..570
FT                   /evidence="ECO:0007744|PDB:2EH0"
FT   STRAND          573..575
FT                   /evidence="ECO:0007744|PDB:2EH0"
FT   STRAND          580..587
FT                   /evidence="ECO:0007744|PDB:2EH0"
FT   STRAND          593..597
FT                   /evidence="ECO:0007744|PDB:2EH0"
FT   STRAND          601..603
FT                   /evidence="ECO:0007744|PDB:2EH0"
FT   STRAND          605..607
FT                   /evidence="ECO:0007744|PDB:2EH0"
FT   STRAND          625..629
FT                   /evidence="ECO:0007744|PDB:2EH0"
FT   STRAND          633..635
FT                   /evidence="ECO:0007744|PDB:2EH0"
FT   HELIX           637..640
FT                   /evidence="ECO:0007744|PDB:2EH0"
FT   TURN            641..645
FT                   /evidence="ECO:0007744|PDB:2EH0"
FT   MOD_RES         O60333-3:663
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692"
FT   MOD_RES         O60333-3:665
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         O60333-3:1141
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
SQ   SEQUENCE   1816 AA;  204476 MW;  AD62F0515978C783 CRC64;
     MSGASVKVAV RVRPFNSRET SKESKCIIQM QGNSTSIINP KNPKEAPKSF SFDYSYWSHT
     SPEDPCFASQ NRVYNDIGKE MLLHAFEGYN VCIFAYGQTG AGKSYTMMGK QEESQAGIIP
     QLCEELFEKI NDNCNEEMSY SVEVSYMEIY CERVRDLLNP KNKGNLRVRE HPLLGPYVED
     LSKLAVTSYT DIADLMDAGN KARTVAATNM NETSSRSHAV FTIVFTQKKH DNETNLSTEK
     VSKISLVDLA GSERADSTGA KGTRLKEGAN INKSLTTLGK VISALAEVDN CTSKSKKKKK
     TDFIPYRDSV LTWLLRENLG GNSRTAMVAA LSPADINYDE TLSTLRYADR AKQIKCNAVI
     NEDPNAKLVR ELKEEVTRLK DLLRAQGLGD IIDIDPLIDD YSGSGSKYLK DFQNNKHRYL
     LASENQRPGH FSTASMGSLT SSPSSCSLSS QVGLTSVTSI QERIMSTPGG EEAIERLKES
     EKIIAELNET WEEKLRKTEA IRMEREALLA EMGVAIREDG GTLGVFSPKK TPHLVNLNED
     PLMSECLLYY IKDGITRVGQ ADAERRQDIV LSGAHIKEEH CIFRSERSNS GEVIVTLEPC
     ERSETYVNGK RVSQPVQLRS GNRIIMGKNH VFRFNHPEQA RAEREKTPSA ETPSEPVDWT
     FAQRELLEKQ GIDMKQEMEK RLQEMEILYK KEKEEADLLL EQQRLDYESK LQALQKQVET
     RSLAAETTEE EEEEEEVPWT QHEFELAQWA FRKWKSHQFT SLRDLLWGNA VYLKEANAIS
     VELKKKVQFQ FVLLTDTLYS PLPPELLPTE MEKTHEDRPF PRTVVAVEVQ DLKNGATHYW
     SLEKLKQRLD LMREMYDRAG EMASSAQDES ETTVTGSDPF YDRFHWFKLV GSSPIFHGCV
     NERLADRTPS PTFSTADSDI TELADEQQDE MEDFDDEAFV DDAGSDAGTE EGSDLFSDGH
     DPFYDRSPWF ILVGRAFVYL SNLLYPVPLI HRVAIVSEKG EVRGFLRVAV QAIAADEEAP
     DYGSGIRQSG TAKISFDNEY FNQSDFSSVA MTRSGLSLEE LRIVEGQGQS SEVITPPEEI
     SRINDLDLKS STLLDGKMVM EGFSEEIGNH LKLGSAFTFR VTVLQASGIL PEYADIFCQF
     NFLHRHDEAF STEPLKNNGR GSPLAFYHVQ NIAVEITESF VDYIKTKPIV FEVFGHYQQH
     PLHLQGQELN SPPQPCRRFF PPPMPLSKPV PATKLNTMSK TSLGQSMSKY DLLVWFEISE
     LEPTGEYIPA VVDHTAGLPC QGTFLLHQGI QRRITVTIIH EKGSELHWKD VRELVVGRIR
     NKPEVDEAAV DAILSLNIIS AKYLKSSHNS SRTFYRFEAV WDSSLHNSLL LNRVTPYGEK
     IYMTLSAYLE LDHCIQPAVI TKDVCMVFYS RDAKISPPRS LRSLFGSGYS KSPDSNRVTG
     IYELSLCKMS DTGSPGMQRR RRKILDTSVA YVRGEENLAG WRPRGDSLIL EHQWELEKLE
     LLHEVEKTRH FLLLRERLGD SIPKSLSDSL SPSLSSGTLS TSTSISSQIS TTTFESAITP
     SESSGYDSGD IESLVDREKE LATKCLQLLT HTFNREFSQV HGSVSDCKLS DISPIGRDPS
     ESSFSSATLT PSSTCPSLVD SRSNSLDQKT PEANSRASSP CPEFEQFQIV PAVETPYLAR
     AGKNEFLNLV PDIEEIRPSS VVSKKGYLHF KEPLYSNWAK HFVVVRRPYV FIYNSDKDPV
     ERGIINLSTA QVEYSEDQQA MVKTPNTFAV CTKHRGVLLQ ALNDKDMNDW LYAFNPLLAG
     TIRSKLSRRC PSQSKY
//
